Silver in the medical devices/equipments: Marketing or real clinical interest?

Pharmacien Hospitalier

Volumn 46, Issue 1, 2011, Pages

  Fontenoy, C ^a   Kamel, S O ^a  

^a CHU DE NANTES   (France)

Author keywords

Medical devices; Review; Silver

Indexed keywords

SILVER DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BLOOD VESSEL PROSTHESIS; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; IMPLANT; INFECTION; MEDICAL INSTRUMENTATION; MITRAL VALVE PROSTHESIS; ORTHOPEDIC PROSTHESIS; REVIEW; TOXICITY; URINARY CATHETER; WOUND CARE; WOUND DRESSING; WOUND HEALING;

EID: 79955618763     PISSN: 07689179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phhp.2010.11.001     Document Type: Review

References (77)

1. Tiller JC, Liao CJ, Lewis K, Klibanov AM. Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci U S A 2001;98:5981-5. (Pubitemid 32488179)
2. Girard CI, Steinmetz E. Épidémiologie, prévention et traitement des infections de prothèses vasculaires. Conférences d'actualisation 2003:575-86 [Epidemiology, prevention and treatment of the vascular infections of prostheses. Conferences of actualization].
3. Sioshansi P. Process for surface treatment of catheter. Artif Organs 1994;18:266-71.
4. Bougle C, Leroyer R. Les cathéters veineux centraux imprégnés de substances anti-infectieuses: aspects techniques et études cliniques (Central venous catheters impregnated with anti-infectious substances: technical aspects and clinical studies). J Clin Pharma 2003;22(3):159-67. (Pubitemid 37322681)
5. Balazs DJ, Triandafillu K, Wood P, et al. Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. Biomaterials 2004;25(11):2139-51. (Pubitemid 38111188)
6. Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R. Molecular and antibiofilmapproaches to prosthetic joint infection. Clin Orthop Relat Res 2003;414:69-88. (Pubitemid 37102138)
7. Rameshbabu N, Sampaih Kumar TS, Prabhakar TG, Sastry VS, Murty KV, Prasad Rao K. Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res A 2007;80(3):581-91. (Pubitemid 46239070)
8. Alt V, Bechert T, Steinrucke P, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004;25(18):4383-91. (Pubitemid 38388599)
9. Bosetti M, Massa A, Torbin E, Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials 2002;23(3):887-92. (Pubitemid 33108964)
10. Morishita M, Miyagi M, Yamasaki Y, Tsuruda K, Kawahara K, Iwamoto Y. Pilot study on the effect of a mouthrinse containing silver zeolite on plaque formation. J Clin Dent 1998;9(4):94-6. (Pubitemid 128506115)
11. Tanagawa M, Yoshida K, Matsumoto S, Yamada T, Atsuta M. Inhibitory effect of antibacterial resin composite against Streptococcus mutans. Caries Res 1999;33(5):366-71.
12. Matsuura T, Abe Y, Sato Y, Okamoto K, Ueshige M, Akagawa Y. Prolonged antimicrobial effect of tissue conditioners containing silver-zeolite. J Dent 1997;25(5):373-7. (Pubitemid 127382102)
13. Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstreaminfections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000;28(9):3332-8.
14. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281(3):261-7. (Pubitemid 29058116)
15. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999;282(6):554-60. (Pubitemid 29380292)
16. Nissen S, Furkert FH. Antimicrobial efficacy of a silver layer on hydrogel lenses. Ophthalmologie 2000;97(9):640-3 [Citation].
17. Amos CF, George MD. Clinical and laboratory testing of a silver-impregnated lens case. Cont Lens Anterior Eye 2006;29(5):247-55. (Pubitemid 44743123)
18. Mackeen PC, Person S, Warner SC, Snipes W, Stevens SE. Silver-coated nylon fiber as an antibacterial agent. Antimicrob Agents Chemother 1987;31(1):93-9. (Pubitemid 17212665)
19. Vigneshwaran N, Kathe A, Varadarajan PV, Nachane RP, Balasubramanya RH. Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol 2007;7(6):1893-7.
20. Vuong T, Franco E, Lehnert S, et al. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. Int J Radiat Oncol Biol Phys 2004;59(3):809-14. (Pubitemid 38748746)
21. Juenger M, Ladwig A, Staecker S, et al. Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin 2006;22(4):739-50.
22. Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Inf 2002;50:202-6. (Pubitemid 37554875)
23. Boswald M, Lugauer S, Regenfus A. Reduced rates of catheter-related bloodstream infections by use of a new silver-impregnated central venous catheter, [abstract no. K-136]. In: Program and abstracts of the 38th interscience conference on antimicrobial agents and chemotherapy, San Diego. Washington: American Society of Microbiology; 1998. p. 542.
24. Khare MD, Bukhari SS, Swann A, Spiers P, McLaren I, Myers J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. J Infect 2007;54(2):146-50. (Pubitemid 46075885)
25. Bambauer R, Mestres P, Pirrung KJ, Sioshansi P. Scanning electron microscopic investigation of catheters for blood access. Artif Organs 1994;18:272-5. (Pubitemid 24140065)
26. Bambauer R, Mestres P, Schiel R. Surface treated large bore catheters with silver based coatings versus untreated catheters for extracorporeal detoxification methods. ASAIO J 1998;44:303-8. (Pubitemid 28328745)
27. Bambauer R, Mestres P, Schiel R. Surface treated catheters with ion beam process for blood access. Ther Apher 2000;4:342-7.
28. Bambauer R, Mestres P, Schiel R. Large bore catheters with surface treatment versus untreated catheters for blood access. J Vasc Access 2001;2:97-105. (Pubitemid 32936757)
29. Groeger JS, Lucas AB, Thaller HAT, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993;218(2):206-10. (Pubitemid 23229149)
30. Ahearn DG, Grace DT, Jennings MJ. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol 2000;41(2):120-5. (Pubitemid 30437605)
31. Srinivasan A, Karchmer T, Richards A, Song X, Perl TM. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 2006;27(1):38-43. (Pubitemid 46939749)
32. Hartmann M, Guttmann J, Muller B, Hallmann T, Geiger K. Reduction of the bacterial load by the silver-coated endotracheal tube (SCET), a laboratory investigation. Technol Health Care 1999;7(5):359-70. (Pubitemid 29488012)
33. Rello J, Quintana E, Ausina V, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med 2006;34(11):2766-72. (Pubitemid 44610941)
34. Harrell AG, Novitsky YW, Kercher KW, et al. In vitro infectability of prosthetic mesh by methicillin-resistant Staphylococcus aureus. Hernia 2006;10(2):120-4.
35. Cohen MS, Stern JM, Vanni AJ, et al. In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surg Infect (Larchmt) 2007;8(3):397-403.
36. Cobb WS, Paton BL, Novitsky YW, et al. Intra-abdominal placement of antimicrobial-impregnated mesh is associated with noninfectious fever. Am Surg 2006;72(12):1205-8 [discussion 1208-9].
37. Ricco JB. InterGard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg 2006;44(2):339-46.
38. Goëau-Brissonnière OA, Fabre D, Leflon-Guibout V, Di Centa I, Nicolas-Chanoine MH, Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 2002;35(6):1260-3. (Pubitemid 44718532)
39. Hernández-Richter T, Wittmann F, Mayr S, et al. Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model. Zentralbl Chir 2003;128(3):244-9. (Pubitemid 36457216)
40. Batt M, Magne JL, Alric P, et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg 2003;38(5):983-9.
41. Grunkemeier G, Wu YX. The Silzone effect: how to reconcile contradictory reports? Eur J Cardiothorac Surg 2004;25:371-5.
42. Medicines and Healthcare products Regulatory Agency. Hight note of early thromboembolic complications associated with Saint-Jude Medical's Silzone® (silver coated) Mechanical heart valve, particularly among mitral valve patients. 1 novembre 1999. http://www.mhra.gov.uk (cited 11/13/2010).
43. Pommer W, Brauner M, Westphale HJ, et al. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study. Am J Kidney Dis 1998;32(5):752-60. (Pubitemid 28516305)
44. Crabtree JH, Burchette RJ, Siddiqi RA, Huen IT, Hadnott LL, Fishman A. The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial Int 2003;23(4):368-74. (Pubitemid 37038734)
45. Massè A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res 2000;53(5):600-4.
46. Coester L, Nepola J, Allen J, Marsh JL. The effects of silver coated external fixation pins. Iowa Orthop J 2006;26:48-53.
47. Hardes J, Ahrens H, Gebert C, et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 2007;28(18):2869-75. (Pubitemid 46482663)
48. Gosheger G, Hardes J, Ahrens H, et al. Silver-coated megaendo-prostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials 2004;25(24):5547-56. (Pubitemid 38610194)
49. Sudmann E, Vik H, Rait M, et al. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med Prog Technol 1994;20(3-4):179-84. (Pubitemid 24358634)
50. Hussain S, Ferguson C. Silver sulphadiazine cream in burns. Emerg Med J 2006;23:929-32.
51. Vermeulen H, Van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds (Review). The Cochrane Library 2008 (issue 3).
52. Meaume S, Vallet D, Morere MN, Teot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care 2005;14:411-9.
53. Jorgensen B, Price P, Andersen KE. The silver-releasing foam dressing. Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: an randomised, controlled trial. Int Wound J 2005;2(1):64-73.
54. Munter KC, Beele H, Russell L, et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J Wound Care 2006;15(5):199-206.
55. Chambers H, Dumville JC, Cullum N. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen 2007;15(2):165-73.
56. Chaloner D. A comparative study of two silver containing dressings, acticoat 7 and Advance in the treatment of chronic venous ulcers. Second World Union of Chronic Venous Ulcers 2004;134.
57. Wunderlich U. Behandlung des Ulcera crusis venosa mit trockenen Wundauflagen. Phasenübergreifende Anwendung eines Silber- imprâgnierten Aktivkohle-Xerodressings. Hautarzt 1991;42:446-50.
58. Bishop JB, Phillips LG, Mustoe TA, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vascul Surg 1992;16:251-7.
59. Blair SD, Backhouse CM, Wright DD, et al. Do dressings influence the healing of chronic venous ulcers? Phlebology 1988;3:129-34.
60. Fumal I, Braham C, Paquet P, Piérard-Franchimont C, Piérard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof of concept study. Dermatology 2002;204(Suppl.):70-4 [260-5].
61. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers (Review). The Cochrane Library 2008; Issue 3.
62. Jude EB, Apelqvist J, Spraul M, Martini J. Prospective randomised controlled study of Hydrofiber® dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med 2007;24:280-8.
63. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns (Review). The Cochrane Library 2008; Issue 4.
64. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004;30(2):140-7.
65. Bishara S, Costagliola M, Shady NH, Saad AD. Effect of silver on burn wound infection control and healing. Review of the literature. Burns 2007;33:139-48. (Pubitemid 46188672)
66. Burd A, Kwok CH, Hung SC, et al. Étude comparative de la cytotoxicité des pansements à l'argent dans des modèles de culture cellulaire monocouche, d'explant cellulaire monocouche, d'explant tissulaire et chez l'animal (Comparative study of the cytotoxicity of the dressings with silver in models of single layer cellular culture, monolayer cellular explant, tissue explant and in the animal). Wound Repair Regen 2007;15:94-104.
67. Rohner C, Ethgen-Bonnet M, Monteiro MC, Wisniewski S, Beretz L. L'argent fait-il le bonheur ? (Does silver gives happiness?). Pharm Hosp 2008;43(174):147-54.
68. Wan AT, Conyers R, Coombs C, Masterton J. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991;37(10 Pt 1):1683-7. (Pubitemid 21892727)
69. Trop M, Rodl S, Hellbom S, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006;60(3):648-52.
70. Haut Conseil de la santé publique. Recommandation de vigilance relative à la sécurité des nanoparticules d'argent (Recommendations of vigilance relating to safety of silver nano particles). Avis du 12 mars 2010.
71. Jun T, Kenneth KY, Chi-Ming H, et al. Topical delivery of silver nanoparticules promotes wound healing. ChemMedChem 2007;2:129-36.
72. Wright JB, Lam L, Buret AG, Olson MG, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver of matrix metalloproteinases cell apoptosis, and healing. Wound Repair Regen 2002;10(3):141-51. (Pubitemid 34760892)
73. Kirsner RS, Orsted H, Wright JB. Matrix metalloproteinases in normal and impaired wound healing: a potential role of nanocrystalline silver. Wounds 2002;13(3C):4-12.
74. Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 2004;29:282-7. (Pubitemid 38658472)
75. Nadworny PL, Burrel RE. A review of assessment techniques for silver technology in wound care. Part I: In vitro methods for assessing antimicrobial activity. Part II: Tissue culture and in vivo methods for determining antimicrobial and anti-inflammatory activity. J Wound Technol 2008;2:6-22.
76. Ricci E, Cassino R, Moffa F, et al. Silver dressings in wound care: a summary of clinical experience in an Italian center. J Wound Technol 2008;2:64-6.
77. Gotschall CS, Morrison MIS, Eichelberger MR. Prospective, randomised study of the efficacy of Mepitel on children with partial-thickness scalds. J Burns Care Rehabil 1998;19(4):279-83. (Pubitemid 28364583)